SPI Infoamtion

1 Table of contents
1.1 List of Tables
1.2 List of Figures

2 Disease Overview
2.1 History of Peritoneal Dialysis
2.2 End-Stage Renal Disease
2.3 Glomerulonephritis
2.4 Diabetes Accentuating Kidney Disease
2.4.1 Global Prevalence of Diabetes
2.4.2 Diabetes Prevalence in Developing Nations

3 Market Characterization
3.1 Overview
3.2 Peritoneal Dialysis Solutions, Revenue ($m), Global, Historic, 2000 -2008
3.3 Peritoneal Dialysis Solutions, Revenue ($m), Global, Forecast, 2008-2015
3.4 Peritoneal Dialysis Solutions, Revenue ($m), Cross Country Analysis, 2008

4 Market Dynamics
4.1 Market Trends
4.1.1 Increasing Uptake of Peritoneal Dialysis in Asian Economies
4.1.2 Low Cost Equipment in Asia Increasing Uptake of Peritoneal Dialysis
4.1.3 Increasing Reimbursement for Peritoneal Dialysis
4.1.4 Positive Perception for Peritoneal Dialysis among Patients and Physicians
4.1.5 Penetration of Peritoneal Dialysis
4.1.6 Increasing Demand for Home Healthcare
4.2 Market Drivers
4.2.1 Increasing Incidence of Diseases to Drive Growth
4.2.2 Expanded Use in the Acute Care Setting
4.2.3 Increasing Awareness to Boost the Peritoneal Dialysis Market
4.2.4 Increasing Demand for Home Healthcare
4.3 Market Restraints
4.3.1 Overview
4.3.2 Nasocomial Infections Post a Formidable Challenge for the Growth of PD
4.3.3 The CANUSA Study
4.3.4 Changes in the Peritoneal Membrane with Time

5 Competitive Landscape
5.1 Overview
5.1.1 Company Share Analysis
5.1.2 Product Comparison

6 Pipeline Analysis
6.1 CATHcarry
6.1.1 Product Status
6.1.2 Product Description
6.1.3 CATHcarry Clinical Trial
6.2 Next-Generation APD Cycler
6.2.1 Product Status
6.2.2 Product Description
6.3 Non PVC CAPD
6.3.1 Product Status
6.3.2 Product Description
6.3.3 Product Description
6.4 Serena Cycler
6.4.1 Product Status
6.4.2 Product Description

7 M&A Landscape
7.1 Acquisition
7.1.1 Fresenius Medical Care Acquires Memphis Kidney and Dialysis Services

8 Appendix
8.1 Methodology
8.2 Secondary Research
8.3 Primary Research
8.4 Models
8.5 Forecasts
8.6 Expert Panels
8.7 Contact US
8.8 Disclaimer

List of Figures
Figure 1: End Stage Renal Disease Patients by Therapy Area, Global, 2008
Figure 2: Glomerulonephritis, Prevalence, Global, 2008
Figure 3: Primary Causes of Kidney Failure
Figure 4: Peritoneal Dialysis Solutions, Revenue ($m), Global, Historic, 2000-2008
Figure 5: Peritoneal Dialysis Solutions, Revenue ($m), Global, Forecast, 2008-2015
Figure 6: Peritoneal Dialysis Solutions, Revenue ($m), Global, Forecast, 2008-2015
Figure 7: Peritoneal Dialysis Versus HD - Perception Analysis
Figure 8: Peritoneal Dialysis, Penetration (%), 2007
Figure 9: Peritoneal Dialysis Solutions, Global, Company Share (%), 2008
Figure 10: GlobalData Methodology

1.1 List of Tables
Table 1: Diabetes Mellitus, Estimated Patient Population ('000's), 2030
Table 2: Peritoneal Dialysis Solutions, Revenue ($m), Global, Historic, 2000-2008
Table 3: Peritoneal Dialysis Solutions, Revenue ($m), Global, Forecast, 2008-2015
Table 4: Peritoneal Dialysis Solutions, Cross Country Analysis, Revenue ($m), 2008
Table 5: Incidence of End-Stage Renal Disease (Per Million Population), 2006
Table 6: Product Comparison, PD, Top Players
Table 7: Peritoneal Dialysis, Pipeline Summary by Territory
Table 8: Peritoneal Dialysis, Pipeline Summary by Developmental Stage
Table 9: CATHcarry, Product Status
Table 10: CATHcarry, Product Description
Table 11: CATHcarry, Clincal Trial
Table 12: Next Generation APD Cycler, Product Status
Table 13: Next Generation APD Cycler, Product Description
Table 14: NON PVC CAPD, Product Status
Table 15: NON PVC CAPD, Product Description
Table 16: Renal Expres, Product Status
Table 17: Renal Express, Product Description
Table 18: Serena Cycler, Product Status
Table 19: Serena Cycler, Product Description
Table 20: Fresenius Medical Care Acquires Memphis Kidney and Dialysis Services